Skip to main content
. Author manuscript; available in PMC: 2015 Apr 15.
Published in final edited form as: Cancer. 2014 Jan 17;120(8):1246–1254. doi: 10.1002/cncr.28508

Table 3.

Two-year and median survival stratified by treatment and analytic methodology.

Two-year survival (95% CI) Median survival (95% CI)

Primary surgery Primary chemotherapy Primary surgery Primary chemotherapy
All Patients
Observational 0.56 (0.55-0.75) 0.36 (0.34-0.38) 28.8 (27.7-29.8) 15.8 (15.1-17.1)
PS reweighted (matched) 0.49 (0.46-0.51) 0.40 (0.38-0.43) 23.5 (21.6-24.6) 18.5 (17.4-19.5)
PS reweighted (IPTW) 0.54 (0.53-0.55) 0.45 (0.44-0.47) 27.2 (26.0-28.2) 21.0 (20.1-21.5)
Instrumental variable
    <Median value of IV 0.49 (0.48-0.51) 23.8 (22.8-24.8)
    ≥Median value of IV 0.50 (0.48-0.52) 24.1 (23.2-25.5)
Intended Treatment
Observational 0.64 (0.63-0.66) 0.58 (0.55-0.62) 34.7 (33.1-36.1) 28.1 (26.2-30.5)
PS reweighted (matched) 0.63 (0.60-0.67) 0.59 (0.55-0.62) 32.7 (30.4-35.6) 28.2 (26.2-30.8)
PS reweighted (IPTW) 0.64 (0.63-0.66) 0.58 (0.56-0.59) 34.7 (33.1-36.1) 28.1 (27.1-28.8)
Instrumental variable
    <Median value of IV 0.62 (0.61-0.64) 32.5 (31.3-34.8)
    ≥Median value of IV 0.64 (0.62-0.66) 35.9 (33.5-37.6)